Tribulus

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 2391 Experts worldwide ranked by ideXlab platform

Ali Ghobadi - One of the best experts on this subject based on the ideXlab platform.

  • Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study
    DARU, 2014
    Co-Authors: Elham Akhtari, Firoozeh Raisi, Mansoor Keshavarz, Hamed Hosseini, Farnaz Sohrabvand, Soodabeh Bioos, Mohammad Kamalinejad, Ali Ghobadi
    Abstract:

    Background: Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test. Results: Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p

  • Tribulus terrestris for treatment of sexual dysfunction in women randomized double blind placebo controlled study
    DARU, 2014
    Co-Authors: Elham Akhtari, Firoozeh Raisi, Mansoor Keshavarz, Hamed Hosseini, Farnaz Sohrabvand, Soodabeh Bioos, Mohammad Kamalinejad, Ali Ghobadi
    Abstract:

    Background: Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test. Results: Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p<0.001), desire (p<0.001), arousal (p=0.037), lubrication (p< 0.001), satisfaction (p<0.001) and pain (p= 0.041) domains of FSFI. Frequency of side effects was similar between the two groups.

Elham Akhtari - One of the best experts on this subject based on the ideXlab platform.

  • Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study
    DARU, 2014
    Co-Authors: Elham Akhtari, Firoozeh Raisi, Mansoor Keshavarz, Hamed Hosseini, Farnaz Sohrabvand, Soodabeh Bioos, Mohammad Kamalinejad, Ali Ghobadi
    Abstract:

    Background: Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test. Results: Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p

  • Tribulus terrestris for treatment of sexual dysfunction in women randomized double blind placebo controlled study
    DARU, 2014
    Co-Authors: Elham Akhtari, Firoozeh Raisi, Mansoor Keshavarz, Hamed Hosseini, Farnaz Sohrabvand, Soodabeh Bioos, Mohammad Kamalinejad, Ali Ghobadi
    Abstract:

    Background: Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test. Results: Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p<0.001), desire (p<0.001), arousal (p=0.037), lubrication (p< 0.001), satisfaction (p<0.001) and pain (p= 0.041) domains of FSFI. Frequency of side effects was similar between the two groups.

Conrad P Earnest - One of the best experts on this subject based on the ideXlab platform.

  • the effects of Tribulus terrestris on body composition and exercise performance in resistance trained males
    International Journal of Sport Nutrition and Exercise Metabolism, 2000
    Co-Authors: Jose Antonio, John Uelmen, Ramsey Rodriguez, Conrad P Earnest
    Abstract:

    The purpose of this study was to determine the effects of the herbal preparation Tribulus terrestris (Tribulus) on body composition and exercise performance in resistance-trained males. Fifteen subjects were randomly assigned to a placebo or Tribulus (3.21 mg per kg body weight daily) group. Body weight, body composition, maximal strength, dietary intake, and mood states were determined before and after an 8-week exercise (periodized resistance training) and supplementation period. There were no changes in body weight, percentage fat, total body water, dietary intake, or mood states in either group. Muscle endurance (determined by the maximal number of repetitions at 100—200% of body weight) increased for the bench and leg press exercises in the placebo group (p < .05; bench press ±28.4%. leg press ±28.6%), while the Tribulus group experienced an increase in leg press strength only (bench press ±3.1 %, not significant; leg press ±28.6%, p < .05). Supplementation with Tribulus does not enhance body composi...

  • the effects of Tribulus terrestris on body composition and exercise performance in resistance trained males
    International Journal of Sport Nutrition and Exercise Metabolism, 2000
    Co-Authors: Jose Antonio, John Uelmen, Ramsey Rodriguez, Conrad P Earnest
    Abstract:

    The purpose of this study was to determine the effects of the herbal preparation Tribulus terrestris (Tribulus) on body composition and exercise performance in resistance-trained males. Fifteen subjects were randomly assigned to a placebo or Tribulus (3.21 mg per kg body weight daily) group. Body weight, body composition, maximal strength, dietary intake, and mood states were determined before and after an 8-week exercise (periodized resistance training) and supplementation period. There were no changes in body weight, percentage fat, total body water, dietary intake, or mood states in either group. Muscle endurance (determined by the maximal number of repetitions at 100-200% of body weight) increased for the bench and leg press exercises in the placebo group (p <.05; bench press +/-28.4%, leg press +/-28.6%), while the Tribulus group experienced an increase in leg press strength only (bench press +/-3.1%, not significant; leg press +/-28.6%, p <.05). Supplementation with Tribulus does not enhance body composition or exercise performance in resistance-trained males.

Firoozeh Raisi - One of the best experts on this subject based on the ideXlab platform.

  • Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study
    DARU, 2014
    Co-Authors: Elham Akhtari, Firoozeh Raisi, Mansoor Keshavarz, Hamed Hosseini, Farnaz Sohrabvand, Soodabeh Bioos, Mohammad Kamalinejad, Ali Ghobadi
    Abstract:

    Background: Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test. Results: Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p

  • Tribulus terrestris for treatment of sexual dysfunction in women randomized double blind placebo controlled study
    DARU, 2014
    Co-Authors: Elham Akhtari, Firoozeh Raisi, Mansoor Keshavarz, Hamed Hosseini, Farnaz Sohrabvand, Soodabeh Bioos, Mohammad Kamalinejad, Ali Ghobadi
    Abstract:

    Background: Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test. Results: Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p<0.001), desire (p<0.001), arousal (p=0.037), lubrication (p< 0.001), satisfaction (p<0.001) and pain (p= 0.041) domains of FSFI. Frequency of side effects was similar between the two groups.

Mohammad Kamalinejad - One of the best experts on this subject based on the ideXlab platform.

  • Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo - controlled study
    DARU, 2014
    Co-Authors: Elham Akhtari, Firoozeh Raisi, Mansoor Keshavarz, Hamed Hosseini, Farnaz Sohrabvand, Soodabeh Bioos, Mohammad Kamalinejad, Ali Ghobadi
    Abstract:

    Background: Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test. Results: Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p

  • Tribulus terrestris for treatment of sexual dysfunction in women randomized double blind placebo controlled study
    DARU, 2014
    Co-Authors: Elham Akhtari, Firoozeh Raisi, Mansoor Keshavarz, Hamed Hosseini, Farnaz Sohrabvand, Soodabeh Bioos, Mohammad Kamalinejad, Ali Ghobadi
    Abstract:

    Background: Tribulus terrestris as a herbal remedy has shown beneficial aphrodisiac effects in a number of animal and human experiments. This study was designed as a randomized double-blind placebo-controlled trial to assess the safety and efficacy of Tribulus terrestris in women with hypoactive sexual desire disorder during their fertile years. Sixty seven women with hypoactive sexual desire disorder were randomly assigned to Tribulus terrestris extract (7.5 mg/day) or placebo for 4 weeks. Desire, arousal, lubrication, orgasm, satisfaction, and pain were measured at baseline and after 4 weeks after the end of the treatment by using the Female Sexual Function Index (FSFI). Two groups were compared by repeated measurement ANOVA test. Results: Thirty women in placebo group and thirty women in drug group completed the study. At the end of the fourth week, patients in the Tribulus terrestris group had experienced significant improvement in their total FSFI (p<0.001), desire (p<0.001), arousal (p=0.037), lubrication (p< 0.001), satisfaction (p<0.001) and pain (p= 0.041) domains of FSFI. Frequency of side effects was similar between the two groups.